Invictus RG Buys 1,629 Shares of Allstate Corporation (The) (ALL)
Invictus RG boosted its stake in shares of Allstate Corporation (The) (NYSE:ALL) by 103.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,211 shares of the insurance provider’s stock after acquiring an additional 1,629 shares during the quarter. Invictus RG’s holdings in Allstate were worth $295,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the business. Arrow Financial Corp raised its stake in shares of Allstate by 100.0% during the 3rd quarter. Arrow Financial Corp now owns 1,106 shares of the insurance provider’s stock worth $102,000 after buying an additional 553 shares in the last quarter. Sandy Spring Bank increased its stake in Allstate by 2.5% in the 2nd quarter. Sandy Spring Bank now owns 1,165 shares of the insurance provider’s stock valued at $103,000 after purchasing an additional 28 shares in the last quarter. Jackson Grant Investment Advisers Inc. increased its stake in Allstate by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,216 shares of the insurance provider’s stock valued at $108,000 after purchasing an additional 5 shares in the last quarter. Financial Engines Advisors L.L.C. purchased a new position in Allstate in the 3rd quarter valued at approximately $116,000. Finally, IHT Wealth Management LLC increased its stake in Allstate by 46.6% in the 2nd quarter. IHT Wealth Management LLC now owns 1,275 shares of the insurance provider’s stock valued at $113,000 after purchasing an additional 405 shares in the last quarter. 76.33% of the stock is owned by institutional investors.
Allstate Corporation (ALL) opened at $102.65 on Thursday. Allstate Corporation has a fifty-two week low of $70.73 and a fifty-two week high of $104.10. The firm has a market capitalization of $36,901.66, a price-to-earnings ratio of 15.15, a P/E/G ratio of 1.98 and a beta of 1.12. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.26 and a quick ratio of 0.26.
Allstate (NYSE:ALL) last issued its earnings results on Wednesday, November 1st. The insurance provider reported $1.60 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.61 by ($0.01). Allstate had a net margin of 7.32% and a return on equity of 13.11%. The firm had revenue of $8.12 billion during the quarter, compared to analyst estimates of $8.07 billion. During the same quarter in the previous year, the business posted $1.26 EPS. Allstate’s revenue was up 3.2% compared to the same quarter last year. equities analysts forecast that Allstate Corporation will post 6.23 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Thursday, November 30th will be issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date of this dividend is Wednesday, November 29th. Allstate’s payout ratio is currently 20.56%.
In other Allstate news, EVP Susan L. Lees sold 4,000 shares of the firm’s stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $100.49, for a total value of $401,960.00. Following the transaction, the executive vice president now directly owns 24,341 shares of the company’s stock, valued at $2,446,027.09. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Suren Gupta sold 103,242 shares of the firm’s stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $98.68, for a total value of $10,187,920.56. The disclosure for this sale can be found here. Insiders sold 432,242 shares of company stock worth $42,827,931 in the last quarter. 1.58% of the stock is owned by insiders.
Several research firms recently weighed in on ALL. Goldman Sachs Group began coverage on Allstate in a research note on Monday. They issued a “neutral” rating and a $104.00 price objective for the company. Wells Fargo & Company set a $110.00 price objective on Allstate and gave the company a “buy” rating in a research note on Thursday, November 16th. B. Riley reaffirmed a “neutral” rating on shares of Allstate in a research note on Monday, November 6th. UBS raised their price target on Allstate from $93.00 to $102.00 and gave the stock a “neutral” rating in a research report on Monday, November 6th. Finally, Zacks Investment Research raised Allstate from a “sell” rating to a “hold” rating in a research report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and four have issued a buy rating to the company. Allstate currently has a consensus rating of “Hold” and a consensus price target of $95.08.
The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.
Receive News & Ratings for Allstate Corporation (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate Corporation (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.